View in EDS HTML Full Text PDF Full Text

Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas.

Saved in:
Bibliographic Details
Title: Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas.
Authors: Lake KE; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Jackson M; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Hull S; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., All S; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Patel AM; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Li X; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Desai NB; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Yilmaz E; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Wolfe H; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Zahid MF; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Li HC; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Awan F; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Kozak MM; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Ramakrishnan Geethakumari P; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States., Kumar KA; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
Source: Frontiers in oncology [Front Oncol] 2025 Jul 31; Vol. 15, pp. 1617087. Date of Electronic Publication: 2025 Jul 31 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40823079
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lake+KE%22">Lake KE</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Jackson+M%22">Jackson M</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Hull+S%22">Hull S</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22All+S%22">All S</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Patel+AM%22">Patel AM</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Li+X%22">Li X</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Desai+NB%22">Desai NB</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Yilmaz+E%22">Yilmaz E</searchLink>; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Wolfe+H%22">Wolfe H</searchLink>; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Zahid+MF%22">Zahid MF</searchLink>; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Li+HC%22">Li HC</searchLink>; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Awan+F%22">Awan F</searchLink>; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Kozak+MM%22">Kozak MM</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Ramakrishnan+Geethakumari+P%22">Ramakrishnan Geethakumari P</searchLink>; Department of Hematology and Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Kumar+KA%22">Kumar KA</searchLink>; Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2025 Jul 31; Vol. 15, pp. 1617087. <i>Date of Electronic Publication: </i>2025 Jul 31 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40823079
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2025.1617087
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1617087
    Titles:
      – TitleFull: Single-agent rituximab and ultra-low-dose adaptive radiotherapy for the treatment of indolent B-cell non-Hodgkin lymphomas.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lake KE
      – PersonEntity:
          Name:
            NameFull: Jackson M
      – PersonEntity:
          Name:
            NameFull: Hull S
      – PersonEntity:
          Name:
            NameFull: All S
      – PersonEntity:
          Name:
            NameFull: Patel AM
      – PersonEntity:
          Name:
            NameFull: Li X
      – PersonEntity:
          Name:
            NameFull: Desai NB
      – PersonEntity:
          Name:
            NameFull: Yilmaz E
      – PersonEntity:
          Name:
            NameFull: Wolfe H
      – PersonEntity:
          Name:
            NameFull: Zahid MF
      – PersonEntity:
          Name:
            NameFull: Li HC
      – PersonEntity:
          Name:
            NameFull: Awan F
      – PersonEntity:
          Name:
            NameFull: Kozak MM
      – PersonEntity:
          Name:
            NameFull: Ramakrishnan Geethakumari P
      – PersonEntity:
          Name:
            NameFull: Kumar KA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 07
              Text: 2025 Jul 31
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1